| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.05 | 0.3 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.3 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.05 | 0.3 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.3 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.3 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.073 | 0.3 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.069 | 0.3 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.3 |